Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function

BACKGROUND: β-Cell dysfunction is a core defect in T2DM, and chronic, sustained hyperglycemia has been implicated in progressive β-cell failure, ie, glucotoxicity. The aim of the present study was to examine the effect of lowering the plasma glucose concentration with dapagliflozin, a glucosuric age...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Endocrinol Metab
Main Authors: Merovci, Aurora, Mari, Andrea, Solis, Carolina, Xiong, Juan, Daniele, Giuseppe, Chavez-Velazquez, Alberto, Tripathy, Devjit, Urban McCarthy, Scheherezada, Abdul-Ghani, Muhammad, DeFronzo, Ralph A.
Format: Artigo
Language:Inglês
Published: Endocrine Society 2015
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422889/
https://ncbi.nlm.nih.gov/pubmed/25710563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-3472
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items